chr22-37754993-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001039141.3(TRIOBP):​c.5487+9A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0292 in 1,613,678 control chromosomes in the GnomAD database, including 1,019 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.041 ( 170 hom., cov: 32)
Exomes 𝑓: 0.028 ( 849 hom. )

Consequence

TRIOBP
NM_001039141.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.40

Publications

1 publications found
Variant links:
Genes affected
TRIOBP (HGNC:17009): (TRIO and F-actin binding protein) This gene encodes a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cell growth. The protein also associates with F-actin and stabilizes F-actin structures. Mutations in this gene have been associated with a form of autosomal recessive nonsyndromic deafness. Multiple alternatively spliced transcript variants that would encode different isoforms have been found for this gene, however some transcripts may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Nov 2008]
TRIOBP Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 22-37754993-A-G is Benign according to our data. Variant chr22-37754993-A-G is described in ClinVar as Benign. ClinVar VariationId is 43860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0723 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIOBPNM_001039141.3 linkc.5487+9A>G intron_variant Intron 13 of 23 ENST00000644935.1 NP_001034230.1 Q9H2D6-1
TRIOBPNM_007032.5 linkc.348+9A>G intron_variant Intron 3 of 13 NP_008963.3 Q9H2D6-7
TRIOBPNM_138632.2 linkc.348+9A>G intron_variant Intron 3 of 7 NP_619538.2 Q9H2D6-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIOBPENST00000644935.1 linkc.5487+9A>G intron_variant Intron 13 of 23 NM_001039141.3 ENSP00000496394.1 Q9H2D6-1

Frequencies

GnomAD3 genomes
AF:
0.0406
AC:
6185
AN:
152182
Hom.:
171
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0746
Gnomad AMI
AF:
0.0844
Gnomad AMR
AF:
0.0232
Gnomad ASJ
AF:
0.0556
Gnomad EAS
AF:
0.000962
Gnomad SAS
AF:
0.0767
Gnomad FIN
AF:
0.0347
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0238
Gnomad OTH
AF:
0.0411
GnomAD2 exomes
AF:
0.0338
AC:
8454
AN:
250168
AF XY:
0.0353
show subpopulations
Gnomad AFR exome
AF:
0.0726
Gnomad AMR exome
AF:
0.0174
Gnomad ASJ exome
AF:
0.0608
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.0319
Gnomad NFE exome
AF:
0.0258
Gnomad OTH exome
AF:
0.0328
GnomAD4 exome
AF:
0.0280
AC:
40974
AN:
1461378
Hom.:
849
Cov.:
33
AF XY:
0.0295
AC XY:
21429
AN XY:
726956
show subpopulations
African (AFR)
AF:
0.0770
AC:
2576
AN:
33470
American (AMR)
AF:
0.0185
AC:
828
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.0570
AC:
1490
AN:
26118
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39690
South Asian (SAS)
AF:
0.0728
AC:
6273
AN:
86178
European-Finnish (FIN)
AF:
0.0310
AC:
1656
AN:
53364
Middle Eastern (MID)
AF:
0.0717
AC:
413
AN:
5764
European-Non Finnish (NFE)
AF:
0.0232
AC:
25821
AN:
1111738
Other (OTH)
AF:
0.0317
AC:
1911
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
2386
4772
7157
9543
11929
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1036
2072
3108
4144
5180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0406
AC:
6188
AN:
152300
Hom.:
170
Cov.:
32
AF XY:
0.0413
AC XY:
3078
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0744
AC:
3093
AN:
41550
American (AMR)
AF:
0.0231
AC:
354
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0556
AC:
193
AN:
3472
East Asian (EAS)
AF:
0.000964
AC:
5
AN:
5188
South Asian (SAS)
AF:
0.0769
AC:
371
AN:
4822
European-Finnish (FIN)
AF:
0.0347
AC:
368
AN:
10618
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0238
AC:
1617
AN:
68036
Other (OTH)
AF:
0.0407
AC:
86
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
303
605
908
1210
1513
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0347
Hom.:
47
Bravo
AF:
0.0400
Asia WGS
AF:
0.0340
AC:
120
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

5487+9A>G in Intron 13 of TRIOBP: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus seq uence and has been identified in 7.2% (269/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.wa shington.edu/EVS; dbSNP rs56016429). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 24, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:3
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 31, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.16
DANN
Benign
0.68
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56016429; hg19: chr22-38151000; API